Viral Load Quantification
Viral Load Quantification - Related Videos
03:40
Plaque Assay–Based Quantification of Viral Load in an Infected Mouse Tissue Sample
0 Views •
2026
Source: Morales Vasquez, D., et al. Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2. J. Vis. Exp. (2021)This video demonstrates the protocol for carrying out plaque assay–based viral titration for quantifying infectious virus levels in tissue sample collected from a virus–infected mouse model.
02:31
Sample Preparation for Luciferase-Based Viral Quantification
0 Views •
2026
Source: Garcia, V., et al. High-throughput Titration of Luciferase-expressing Recombinant Viruses. J. Vis. Exp. (91), e51890, doi:10.3791/51890 (2014).This video demonstrates the preparation of cell culture samples to assess viral load using a luciferase-based assay. It outlines the process of infecting epithelial cells with a genetically modified virus, transferring viral supernatants and standards into assay wells, and promoting viral entry through centrifugation and incubation. The...
02:27
Measuring Hepatitis C Viral Load Using Quantitative Reverse Transcription Polymerase Chain Reaction
0 Views •
2026
Source: Ren, S., et al. A Protocol for Analyzing Hepatitis C Virus Replication. J. Vis. Exp. (2014).This video demonstrates the procedure for quantifying Hepatitis C viral RNA using quantitative reverse transcription PCR to measure viral load in infected cell cultures.
02:49
Quantification of Helicobacter pylori Load in an Infected Mouse Stomach
0 Views •
2025
In this video, we describe a protocol to quantify Helicobacter pylori load in mouse stomach tissues post-infection to confirm its colonization.
13:58
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
0 Views •
Cited by 10 •
2011
Quantifying levels of HIV-1 RNA in plasma and sequencing single HIV-1 genomes from individuals with viral loads below the limit of detection (50-75 copies/ml) is difficult. Here we describe how to extract and quantify plasma viral RNA using a real time PCR assay that reliably measures HIV-1 RNA down to 0.3 copies/ml and how to amplify viral genomes by single genome sequencing, from samples with very low viral loads.
FAQs
Standards provide reference points linking fluorescence measurements to estimated viral nucleic acid copy numbers. During quantitative PCR or reverse-transcription quantitative PCR, the signal from an unknown sample is compared with signals generated from these known concentrations. This comparison allows researchers to estimate the amount of viral genetic material rather than reporting detection alone.
Molecular assays detect viral genetic material, which may remain present in noninfectious viral particles. Consequently, a sample can contain measurable nucleic acid without representing an equivalent amount of virus capable of infection. Interpreting viral load alongside infectivity assays, when relevant, helps distinguish genetic detection from infectious-virus activity.
Measurements collected over time can show whether the amount of viral material is increasing, decreasing, or remaining relatively stable. These patterns help researchers examine infection dynamics, monitor responses to antiviral treatment, and investigate disease progression. The results are most informative when considered with clinical findings rather than treated as an isolated indicator.
A typical workflow begins by extracting viral nucleic acids from a biological sample. The extracted material is then amplified using quantitative PCR or reverse-transcription quantitative PCR, depending on the nucleic acid being analyzed. Fluorescence is measured during amplification and compared with standards of known concentration to estimate the sample's viral copy number.
Researchers use these measurements to follow infection over time, evaluate changes associated with antiviral treatment, and study disease dynamics. Viral load data also support investigations of transmission and pathogenesis, the processes through which infection produces disease. These applications make the measurement useful for connecting molecular observations with broader biological patterns.
Interpretation should incorporate clinical findings and, when the research question requires it, infectivity assays. A nucleic acid measurement indicates that viral genetic material was detected and estimated, but it does not by itself establish that all detected particles are infectious. Combining complementary evidence produces a more cautious assessment of infection status and biological significance.